ST · Financial Services

Novakand Pharma AB (publ) (LARK)

Asset Management

Novakand Pharma AB (publ) (LARK) is listed on ST in the Financial Services sector. Industry: Asset Management. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for LARK

P/E ratio

18.00

Novakand Pharma AB (publ) (LARK) — FAQ

What is LARK's P/E ratio?

The price-to-earnings (P/E) ratio for Novakand Pharma AB (publ) (LARK) is 18.00 (data as of 2026-05-24).

Does Novakand Pharma AB (publ) pay a dividend?

Dividend yield is not available in the current snapshot for Novakand Pharma AB (publ) (LARK). Check the MyAverix Finance app for the latest dividend data.

What sector is Novakand Pharma AB (publ) in?

Novakand Pharma AB (publ) (LARK) is classified in the Financial Services sector (Asset Management industry).

What exchange is LARK listed on?

LARK is listed on ST.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Financial Services companies

Administradora Americana de Inversiones S.A. (AAISA) Aflac Incorporated (A1FL34) Agricultural Bank Of China (1288) AIA Group Ltd (1299) American International Group, Inc. (AIGB34) Ameriprise Financial Inc. (A1MP34) Arthur J. Gallagher & Co. (A1JG34) Banco Santander S.A. (BSD2)